Snowball logo
logo
NARI_logo

Inari Medical, Inc

NARI NASDAQ Delisted
-- $$0.00  (0%)
Estimate
EPS
-1.35
Forecast
EPS (FWD)
-0.002
About the company
Ticker
NARI
ISIN
US45332Y1091
Country
United States of America
Sector (GICS)
Healthcare
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.

Frequently asked questions

What sector does Inari Medical, Inc (NARI) operate in?

Inari Medical, Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Inari Medical, Inc (NARI) Earnings Per Share (EPS)?

The trailing EPS is -$1.35, and the forward EPS is -$0.00.

Does Inari Medical, Inc (NARI) pay dividends?

No. Inari Medical, Inc does not pay a dividend.

When is Inari Medical, Inc (NARI) next earnings report?

Inari Medical, Inc is expected to release its next earnings report on March 31, 2025.